Oral aprepitant for prevention of chemotherapy-induced nausea and vomiting in Chinese patients receiving high-dose cisplatin

Trial Profile

Oral aprepitant for prevention of chemotherapy-induced nausea and vomiting in Chinese patients receiving high-dose cisplatin

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Jul 2011

At a glance

  • Drugs Aprepitant; Dexamethasone; Granisetron
  • Indications Chemotherapy-induced nausea and vomiting
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Jul 2011 New trial record
    • 07 Jul 2011 Primary endpoint 'Complete-control-of-nausea-and-vomiting' has been met.
    • 07 Jul 2011 Results presented at the 14th World Conference on Lung Cancer.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top